FDA Inspection 1095042 — Beth Israel Deaconess Medical Center

Beth Israel Deaconess Medical Center — FEI 1273763

The FDA completed an inspection of Beth Israel Deaconess Medical Center on June 10, 2019 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 10, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Boston, MA (United States)